Clinical Trials Browser

INDUSTRY × Interventional × Pleural Effusion, Malignant × Clear all

NCT06097962 2026-03-20

Safety and Efficacy of NK510 to Treat NSCLC

Phase EARLY_PHASE1 Recruiting

Pleural Effusion, Malignant

NCT04914598 2026-01-02

A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

Phase 3 Active not recruiting

Pleural Effusion, Malignant

NCT02649894 2025-12-11

SWIFT

Phase NA Completed

119 enrolled 16 charts

Pleural Effusion, Malignant

NCT02227732 2025-11-26

A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions

Phase NA Completed

Pleural Effusion, Malignant

NCT06210685 2025-08-11

The ACES Study for Aseptic Pleural Effusion

Phase NA Active not recruiting

Pleural Effusion, Pleural Effusion, Malignant

NCT05543330 2025-07-20

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT06740019 2025-04-04

A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Phase 1 Recruiting

MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

NCT06726564 2024-12-10

A Study of MT027 in Patients with Pleural Malignant Tumors

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasm Metastasis, Pleural Effusion, Malignant

NCT00791154 2024-08-23

SCLC

Phase 1/2 Terminated

213 enrolled 16 charts

Lung Neoplasms, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Phase 1/2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

NCT01997190 2023-08-25

MpeTK01

Phase 1 Completed

BreastGynecologicOther solid neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Mesothelioma, Ovarian Neoplasms, Pleural Effusion, Malignant

NCT05923515 2023-06-28

A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Phase 1 Unknown

Pleural Effusion, Malignant

NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Phase 3 Terminated

2,549 enrolled 19 charts

Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

NCT04123886 2022-05-06

A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion

Phase 1 Completed

Pleural Effusion, Malignant

NCT03869697 2022-02-02

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions

Phase 1 Completed

Pleural Effusion, Malignant

NCT04254445 2020-02-18

Use of Guidance Videos to Increase Engagement and Decrease Anxiety in Patients Undergoing Pleural Tap

Phase NA Unknown

Pleural Effusion, Pleural Effusion, Malignant

NCT03736122 2018-11-08

A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites

Phase 1/2 Unknown

Pleural Effusion, Malignant

NCT00005645 2018-09-18

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Phase 2 Withdrawn

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant

NCT02429726 2015-04-29

Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

Phase 2 Unknown

Pleural Effusion, Malignant

NCT01327235 2014-08-01

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Phase 2 Completed

Pleural Effusion, Malignant

NCT02191540 2014-07-23

Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients

Phase 3 Completed

Pleural Effusion, Malignant

NCT00343291 2011-06-07

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Phase 2 Completed

121 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00099541 2009-11-23

Non-small Cell Lung Cancer Registry

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant